NO303620B1 - FremgangsmÕte for fremstilling av et farmas°ytisk preparat for bekjempelse av patogene mikroorganismer i mennesker og dyr - Google Patents
FremgangsmÕte for fremstilling av et farmas°ytisk preparat for bekjempelse av patogene mikroorganismer i mennesker og dyr Download PDFInfo
- Publication number
- NO303620B1 NO303620B1 NO922379A NO922379A NO303620B1 NO 303620 B1 NO303620 B1 NO 303620B1 NO 922379 A NO922379 A NO 922379A NO 922379 A NO922379 A NO 922379A NO 303620 B1 NO303620 B1 NO 303620B1
- Authority
- NO
- Norway
- Prior art keywords
- lia
- streptococcus lactis
- strain
- added
- preparation
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 241001465754 Metazoa Species 0.000 title claims abstract description 11
- 244000000010 microbial pathogen Species 0.000 title claims abstract description 9
- 238000000034 method Methods 0.000 title claims description 9
- 244000005700 microbiome Species 0.000 claims abstract description 20
- 235000014897 Streptococcus lactis Nutrition 0.000 claims abstract description 14
- 206010012735 Diarrhoea Diseases 0.000 claims abstract description 11
- 239000000825 pharmaceutical preparation Substances 0.000 claims abstract description 7
- 239000003937 drug carrier Substances 0.000 claims abstract description 6
- 230000002496 gastric effect Effects 0.000 claims abstract description 6
- 230000035899 viability Effects 0.000 claims abstract description 3
- 241000894006 Bacteria Species 0.000 claims description 19
- 244000057717 Streptococcus lactis Species 0.000 claims description 13
- 230000002401 inhibitory effect Effects 0.000 claims description 7
- 235000021262 sour milk Nutrition 0.000 claims description 5
- 235000020167 acidified milk Nutrition 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 241001273783 Carex scoparia Species 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 3
- 235000014048 cultured milk product Nutrition 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 235000015141 kefir Nutrition 0.000 claims description 2
- 230000000644 propagated effect Effects 0.000 claims description 2
- 239000007858 starting material Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 235000013618 yogurt Nutrition 0.000 claims description 2
- 235000020186 condensed milk Nutrition 0.000 claims 1
- 230000000369 enteropathogenic effect Effects 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 206010017964 Gastrointestinal infection Diseases 0.000 abstract 1
- 241000194035 Lactococcus lactis Species 0.000 abstract 1
- 230000000968 intestinal effect Effects 0.000 description 7
- 235000013336 milk Nutrition 0.000 description 7
- 239000008267 milk Substances 0.000 description 7
- 210000004080 milk Anatomy 0.000 description 7
- 230000001580 bacterial effect Effects 0.000 description 5
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 229940088710 antibiotic agent Drugs 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 210000000936 intestine Anatomy 0.000 description 4
- 108010062877 Bacteriocins Proteins 0.000 description 3
- 244000052616 bacterial pathogen Species 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 241000589516 Pseudomonas Species 0.000 description 2
- 241000607142 Salmonella Species 0.000 description 2
- 241000607768 Shigella Species 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 239000008186 active pharmaceutical agent Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 210000004051 gastric juice Anatomy 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000011275 oncology therapy Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 208000034309 Bacterial disease carrier Diseases 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 206010022678 Intestinal infections Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000607734 Yersinia <bacteria> Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000002850 nasal mucosa Anatomy 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 208000026775 severe diarrhea Diseases 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 244000005714 skin microbiome Species 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
- B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
- B01J23/54—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals combined with metals, oxides or hydroxides provided for in groups B01J23/02 - B01J23/36
- B01J23/56—Platinum group metals
- B01J23/62—Platinum group metals with gallium, indium, thallium, germanium, tin or lead
- B01J23/622—Platinum group metals with gallium, indium, thallium, germanium, tin or lead with germanium, tin or lead
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1236—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt using Leuconostoc, Pediococcus or Streptococcus sp. other than Streptococcus Thermophilus; Artificial sour buttermilk in general
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J27/00—Catalysts comprising the elements or compounds of halogens, sulfur, selenium, tellurium, phosphorus or nitrogen; Catalysts comprising carbon compounds
- B01J27/06—Halogens; Compounds thereof
- B01J27/08—Halides
- B01J27/10—Chlorides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C5/00—Preparation of hydrocarbons from hydrocarbons containing the same number of carbon atoms
- C07C5/22—Preparation of hydrocarbons from hydrocarbons containing the same number of carbon atoms by isomerisation
- C07C5/2206—Catalytic processes not covered by C07C5/23 - C07C5/31
- C07C5/226—Catalytic processes not covered by C07C5/23 - C07C5/31 with metals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2521/00—Catalysts comprising the elements, oxides or hydroxides of magnesium, boron, aluminium, carbon, silicon, titanium, zirconium or hafnium
- C07C2521/02—Boron or aluminium; Oxides or hydroxides thereof
- C07C2521/04—Alumina
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2523/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group C07C2521/00
- C07C2523/14—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group C07C2521/00 of germanium, tin or lead
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2523/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group C07C2521/00
- C07C2523/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group C07C2521/00 of noble metals
- C07C2523/40—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group C07C2521/00 of noble metals of the platinum group metals
- C07C2523/42—Platinum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2523/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group C07C2521/00
- C07C2523/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group C07C2521/00 of noble metals
- C07C2523/54—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group C07C2521/00 of noble metals combined with metals, oxides or hydroxides provided for in groups C07C2523/02 - C07C2523/36
- C07C2523/56—Platinum group metals
- C07C2523/62—Platinum group metals with gallium, indium, thallium, germanium, tin or lead
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/885—Streptococcus
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Veterinary Medicine (AREA)
- Materials Engineering (AREA)
- Food Science & Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Physiology (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Dairy Products (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8904332A SE465206B (sv) | 1989-12-22 | 1989-12-22 | Farmaceutisk beredning foer bekaempning av patogena tarmbakterier |
| PCT/SE1990/000850 WO1991009608A1 (en) | 1989-12-22 | 1990-12-19 | Pharmaceutical preparation for controlling pathogenic intestinal bacteria |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO922379D0 NO922379D0 (no) | 1992-06-17 |
| NO922379L NO922379L (no) | 1992-08-12 |
| NO303620B1 true NO303620B1 (no) | 1998-08-10 |
Family
ID=20377846
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO922379A NO303620B1 (no) | 1989-12-22 | 1992-06-17 | FremgangsmÕte for fremstilling av et farmas°ytisk preparat for bekjempelse av patogene mikroorganismer i mennesker og dyr |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5322686A (fi) |
| EP (1) | EP0506817B1 (fi) |
| JP (1) | JP3140049B2 (fi) |
| AT (1) | ATE135228T1 (fi) |
| AU (1) | AU641722B2 (fi) |
| CA (1) | CA2070687C (fi) |
| DE (1) | DE69025953T2 (fi) |
| DK (1) | DK0506817T3 (fi) |
| ES (1) | ES2084806T3 (fi) |
| FI (1) | FI96744C (fi) |
| NO (1) | NO303620B1 (fi) |
| SE (1) | SE465206B (fi) |
| WO (1) | WO1991009608A1 (fi) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5705152A (en) * | 1990-10-26 | 1998-01-06 | Interprise Limited | Antimicrobial composition |
| DE69223615T2 (de) * | 1992-07-06 | 1998-04-09 | Nestle Sa | Lactobacillus Acidophilus enthaltende Antigastritis-Mittel |
| US5478557A (en) * | 1992-07-29 | 1995-12-26 | The United States Of America, As Represented By The Secretary Of Agriculture | Probiotic for control of salmonella |
| US5714378A (en) * | 1995-03-31 | 1998-02-03 | The United States Of America As Represented By The Secretary Of The Navy | Pseudomonas chlororaphis microorganism polyurethane degrading enzyme obtained therefrom and method of using enzyme |
| AT405235B (de) * | 1995-11-02 | 1999-06-25 | Helmut Dr Viernstein | Probiotisch wirksame formulierung |
| GR1002668B (el) * | 1996-03-15 | 1997-04-14 | N | Μεθοδος προσθηκης στειρου αεριου αζωτου και φαρμακολογικως δραστικων ουσιων εις στερεο γιαουρτι. |
| US5902578A (en) * | 1996-03-25 | 1999-05-11 | Abbott Laboratories | Method and formula for the prevention of diarrhea |
| US20020035071A1 (en) * | 1997-07-08 | 2002-03-21 | Josef Pitha | Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites |
| US8563522B2 (en) * | 1997-07-08 | 2013-10-22 | The Iams Company | Method of maintaining and/or attenuating a decline in quality of life |
| US20060116330A1 (en) * | 1997-07-08 | 2006-06-01 | The Iams Company | Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose |
| WO2002013982A1 (en) | 2000-08-11 | 2002-02-21 | Whitlock David R | Compositions including ammonia oxidizing bacteria to increase production of nitric oxide and nitric oxide precursors and methods of using same |
| US20050244382A9 (en) * | 2002-01-11 | 2005-11-03 | Whitlock David R | Compositions including ammonia oxidizing bacteria and methods of using same |
| US20050100559A1 (en) * | 2003-11-07 | 2005-05-12 | The Procter & Gamble Company | Stabilized compositions comprising a probiotic |
| US7785635B1 (en) | 2003-12-19 | 2010-08-31 | The Procter & Gamble Company | Methods of use of probiotic lactobacilli for companion animals |
| US20050152884A1 (en) * | 2003-12-19 | 2005-07-14 | The Procter & Gamble Company | Canine probiotic Bifidobacteria globosum |
| US8877178B2 (en) * | 2003-12-19 | 2014-11-04 | The Iams Company | Methods of use of probiotic bifidobacteria for companion animals |
| US8894991B2 (en) * | 2003-12-19 | 2014-11-25 | The Iams Company | Canine probiotic Lactobacilli |
| US20050158294A1 (en) * | 2003-12-19 | 2005-07-21 | The Procter & Gamble Company | Canine probiotic Bifidobacteria pseudolongum |
| FR2883131B1 (fr) * | 2005-03-16 | 2007-04-27 | Sarl Caribou T G Sarl | Procede de preparation de grains de kefir, et application aux installations de preparation de soupes pour animaux d'elevage |
| JP4938006B2 (ja) * | 2005-05-31 | 2012-05-23 | ザ・アイムス・カンパニー | ネコ科動物プロバイオティク・ビフィドバクテリア |
| JP4938005B2 (ja) * | 2005-05-31 | 2012-05-23 | ザ・アイムス・カンパニー | ネコ科動物プロバイオティックであるラクトバシラス |
| WO2008093303A2 (en) | 2007-02-01 | 2008-08-07 | The Iams Company | Method for decreasing inflammation and stress in a mammal using glucose antimetaboltes, avocado or avocado extracts |
| US9771199B2 (en) | 2008-07-07 | 2017-09-26 | Mars, Incorporated | Probiotic supplement, process for making, and packaging |
| RU2011124506A (ru) | 2008-11-17 | 2012-12-27 | Эссум Аб | Фармацевтический препарат, содержащий комбинацию штаммов streptococcus и штаммов lactobacillus |
| US10104903B2 (en) | 2009-07-31 | 2018-10-23 | Mars, Incorporated | Animal food and its appearance |
| CA2946050C (en) | 2014-04-15 | 2023-08-29 | Aobiome Llc | Ammonia-oxidizing nitrosomonas eutropha strain d23 |
| US11225640B2 (en) | 2014-04-15 | 2022-01-18 | Aobiome Llc | Ammonia oxidizing bacteria for treatment of psoriasis |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1190386A (en) * | 1966-06-28 | 1970-05-06 | Green Cross Corp | Process for producing the Lactic Acid Bacteria Drugs |
| SU1333709A1 (ru) * | 1985-11-29 | 1987-08-30 | Всесоюзный Научно-Исследовательский Институт Молочной Промышленности | Штамм SтRертососсUS LастIS,используемый в заквасках дл приготовлени кисломолочных продуктов |
| JPS62201823A (ja) * | 1986-02-28 | 1987-09-05 | Freunt Ind Co Ltd | 腸内有用細菌含有物およびその製造方法 |
| SU1423586A1 (ru) * | 1986-06-09 | 1988-09-15 | Институт Микробиологии И Вирусологии Ан Казсср | Способ приготовлени закваски "Казахсил" дл силосовани кормов |
| US5143845A (en) * | 1986-09-03 | 1992-09-01 | Toa Pharmaceutical Co., Ltd. | Mixture of saccarifying lactic acid producing and butyric acid producing bacteria |
| JP2612001B2 (ja) * | 1987-09-04 | 1997-05-21 | フロイント産業株式会社 | 腸内有用細菌含有顆粒およびその製造方法 |
| AU4055689A (en) * | 1988-08-03 | 1990-03-05 | Wisconsin Alumni Research Foundation | Biological inoculant effective against aphanomyces |
-
1989
- 1989-12-22 SE SE8904332A patent/SE465206B/sv unknown
-
1990
- 1990-12-19 CA CA002070687A patent/CA2070687C/en not_active Expired - Fee Related
- 1990-12-19 DE DE69025953T patent/DE69025953T2/de not_active Expired - Fee Related
- 1990-12-19 US US07/861,796 patent/US5322686A/en not_active Expired - Fee Related
- 1990-12-19 JP JP03502116A patent/JP3140049B2/ja not_active Expired - Fee Related
- 1990-12-19 EP EP91901938A patent/EP0506817B1/en not_active Expired - Lifetime
- 1990-12-19 AU AU70482/91A patent/AU641722B2/en not_active Ceased
- 1990-12-19 DK DK91901938.0T patent/DK0506817T3/da active
- 1990-12-19 ES ES91901938T patent/ES2084806T3/es not_active Expired - Lifetime
- 1990-12-19 AT AT91901938T patent/ATE135228T1/de not_active IP Right Cessation
- 1990-12-19 WO PCT/SE1990/000850 patent/WO1991009608A1/en active IP Right Grant
-
1992
- 1992-06-17 NO NO922379A patent/NO303620B1/no not_active IP Right Cessation
- 1992-06-17 FI FI922825A patent/FI96744C/fi active
Also Published As
| Publication number | Publication date |
|---|---|
| AU7048291A (en) | 1991-07-24 |
| FI96744B (fi) | 1996-05-15 |
| NO922379L (no) | 1992-08-12 |
| DK0506817T3 (da) | 1996-04-15 |
| ES2084806T3 (es) | 1996-05-16 |
| AU641722B2 (en) | 1993-09-30 |
| ATE135228T1 (de) | 1996-03-15 |
| CA2070687C (en) | 2001-04-10 |
| EP0506817B1 (en) | 1996-03-13 |
| FI96744C (fi) | 1996-08-26 |
| SE8904332D0 (sv) | 1989-12-22 |
| JP3140049B2 (ja) | 2001-03-05 |
| DE69025953T2 (de) | 1996-09-05 |
| CA2070687A1 (en) | 1991-06-23 |
| SE8904332L (sv) | 1991-06-23 |
| FI922825A (fi) | 1992-06-17 |
| WO1991009608A1 (en) | 1991-07-11 |
| FI922825A0 (fi) | 1992-06-17 |
| US5322686A (en) | 1994-06-21 |
| EP0506817A1 (en) | 1992-10-07 |
| JPH05502873A (ja) | 1993-05-20 |
| SE465206B (sv) | 1991-08-12 |
| NO922379D0 (no) | 1992-06-17 |
| DE69025953D1 (de) | 1996-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO303620B1 (no) | FremgangsmÕte for fremstilling av et farmas°ytisk preparat for bekjempelse av patogene mikroorganismer i mennesker og dyr | |
| CN100378214C (zh) | 益生细菌:发酵乳杆菌 | |
| CN113583972B (zh) | 一株可降低抗生素耐药性的大肠杆菌噬菌体及其应用 | |
| AU662601B2 (en) | Probiotic for control of salmonella | |
| MXPA06013253A (es) | Metodo y composicion para reducir la enfermedad de e. coli disease y mejorar el rendimiento utilizando bacilos. | |
| Rimler | Studies of the pathogenic avian haemophili | |
| JPS5911177A (ja) | 新規乳酸桿菌 | |
| RU2437563C1 (ru) | Пробиотическая кормовая добавка | |
| EP0271364B1 (en) | Preparation suitable for treating enteric disorders | |
| Hummel et al. | Inhibition ofCandida albicans by Escherichia coli in vitro and in the germfree mouse | |
| EP0801675B1 (en) | Saccharomyces treatment to diminish campylobacter and salmonella populations in poultry | |
| Umoh et al. | Antibiogram of staphylococcal strains isolated from milk and milk‐products | |
| KR101830900B1 (ko) | 신규한 조류 병원성 대장균 특이 박테리오파지 ec13 및 이를 포함하는 항균 조성물 | |
| Popoff et al. | Survey of neuraminidase production by Clostridium butyricum, Clostridium beijerinckii, and Clostridium difficile strains from clinical and nonclinical sources | |
| US8414878B2 (en) | Irilis biopreparation based on bacillus-strain bacteria, bacillus subtilis and bacillus licheniformis contained therein | |
| CN115651860B (zh) | 凝结芽孢杆菌bc-hyc株及其应用 | |
| Cruickshank | The experimental transformation of the intestinal flora | |
| KR20020013670A (ko) | 양식어류의 사료첨가제용 미생물 제제 및 그 제조방법 | |
| RU2120991C1 (ru) | Штамм bifidobacterium adolescentis г 7513, используемый для получения бифидосодержащих препаратов - эубиотиков и продуктов лечебно-диетического питания | |
| Smith et al. | Furazolidone resistance in Salmonella gallinarum: the relationship between in vitro and in vivo determinations of resistance | |
| US7678557B2 (en) | Methods for the accumulation and retention of immune-enhancing, bacterial-derived ribonucleotides (ORN) in bacteria | |
| US6645515B1 (en) | Bacteriostatic composition for salmonellae | |
| Ewald | Enterotoxin production by Staphyloccucus aureus strains isolated from Danish foods | |
| KR20210076221A (ko) | 페디오코커스 펜토사세우스 kcc-45 및 이를 포함하는 조성물 | |
| Behling et al. | Competitive exclusion of Salmonella enteritidis in chicks by treatment with a single culture plus dietary lactose |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1K | Patent expired |